Allergy & Asthma Network is pleased to see the Trump Administration take action to reduce drug prices, including prices for allergy and asthma medications.
Learn about the renewed federal COVID-19 public health emergency (PHE) declaration for telehealth that includes telehealth expansions.
Learn about our efforts that bring an end to racial disparities affecting people with asthma, allergies and related conditions.
Allergy & Asthma Network and other health groups release a statement that national air quality standards for ozone pollution violate the Clean Air Act.
Allergy & Asthma Network federal advocacy efforts supported critical healthcare needs for people with asthma and allergies during COVID-19.
Read a summary of the 2020 virtual AADCH event and learn about priority legislative & regulatory issues for patients living with asthma & allergies.
The Network celebrates its 35th anniversary with a virtual Capitol Hill day, launch of new programs, more.
The Network advocates against step therapy which limits patient treatment options, and can be dangerous and time-consuming. Learn what you can do about it.
The Network invites you to its annual Allergy & Asthma Day on Capitol Hill (AADCH20).
News regarding the Allergy & Asthma Network’s successful advocacy efforts leading to increases in federal program funding and policy provisions.
The Network continues to advocate for airlines to stock epinephrine auto-injectors in emergency medical kits for the treatment of anaphylaxis.
Allergy & Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient’s voice is heard in legislation and policy issues is an important part of the Network’s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care.
The COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the “Preserving Patient Savings on Drug Costs Act.” This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.